Casey is a Nashville, TN native who has been working in the clinical trials space for over 16 years with experience leading trials from proof of concept through post marketing in Oncology and vaccine development. After spending 13 years in site level leadership at Vanderbilt Ingram Cancer Center and Sarah Cannon she moved to a development role in Oncology at Eli Lilly in 2021. Casey is passionate about bringing the best medicines to patients and increasing support and access in all settings.